VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | IMS nursing highlights: talquetamab-induced toxicities, QoL tools & psychological impact of MRD

Monica Morris, MSc, RN, Myeloma UK, Edinburgh, UK, shares some of the most exciting abstracts that were shared in one of the Nursing Symposia oral abstracts sessions, including managing oral and skin toxicities induced by talquetamab treatment, patients’ opinions on quality of life (QoL) tools, and the psychological impact of measurable residual disease (MRD) results on patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter